Cargando…
Tumor Targeting via Integrin Ligands
Selective and targeted delivery of drugs to tumors is a major challenge for an effective cancer therapy and also to overcome the side-effects associated with current treatments. Overexpression of various receptors on tumor cells is a characteristic structural and biochemical aspect of tumors and dis...
Autores principales: | Marelli, Udaya Kiran, Rechenmacher, Florian, Sobahi, Tariq Rashad Ali, Mas-Moruno, Carlos, Kessler, Horst |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757457/ https://www.ncbi.nlm.nih.gov/pubmed/24010121 http://dx.doi.org/10.3389/fonc.2013.00222 |
Ejemplares similares
-
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
por: Mas-Moruno, Carlos, et al.
Publicado: (2010) -
Hydrogel Micropillars with Integrin Selective Peptidomimetic Functionalized Nanopatterned Tops: A New Tool for the Measurement of Cell Traction Forces Transmitted through α(v)β(3)- or α(5)β(1)-Integrins
por: Rahmouni, Sabri, et al.
Publicado: (2013) -
Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion
por: Pallarola, Diego, et al.
Publicado: (2014) -
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
por: Kapp, Tobias G., et al.
Publicado: (2017) -
Towards the cell-instructive bactericidal substrate: exploring the combination of nanotopographical features and integrin selective synthetic ligands
por: Fraioli, Roberta, et al.
Publicado: (2017)